212 related articles for article (PubMed ID: 19025335)
21. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
[TBL] [Abstract][Full Text] [Related]
22. Integrated testing strategy (ITS) for bioaccumulation assessment under REACH.
Lombardo A; Roncaglioni A; Benfentati E; Nendza M; Segner H; Fernández A; Kühne R; Franco A; Pauné E; Schüürmann G
Environ Int; 2014 Aug; 69():40-50. PubMed ID: 24806447
[TBL] [Abstract][Full Text] [Related]
23. Introduction to the EU REACH legislation.
Grindon C; Combes R
Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
[TBL] [Abstract][Full Text] [Related]
24. In vitro tests within the REACH information strategies.
Louekari K; Sihvonen K; Kuittinen M; Sømnes V
Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
[TBL] [Abstract][Full Text] [Related]
25. Integrated testing strategies for use in the EU REACH system.
Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
Altern Lab Anim; 2006 Aug; 34(4):407-27. PubMed ID: 16945008
[TBL] [Abstract][Full Text] [Related]
26. A critical evaluation of the 2011 ECHA reports on compliance with the REACH and CLP regulations and on the use of alternatives to testing on animals for compliance with the REACH regulation.
Spielmann H; Sauer UG; Mekenyan O
Altern Lab Anim; 2011 Oct; 39(5):481-93. PubMed ID: 22103941
[TBL] [Abstract][Full Text] [Related]
27. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)).
Rovida C; Hartung T
ALTEX; 2009; 26(3):187-208. PubMed ID: 19907906
[TBL] [Abstract][Full Text] [Related]
28. The regulatory acceptance of alternatives in the European Union.
Warbrick EV; Evans PF
Altern Lab Anim; 2004 Jun; 32 Suppl 1B():657-61. PubMed ID: 23581154
[TBL] [Abstract][Full Text] [Related]
29. CON4EI: Development of serious eye damage and eye irritation testing strategies with respect to the requirements of the UN GHS/EU CLP hazard categories.
Verstraelen S; Van Rompay AR
Toxicol In Vitro; 2018 Jun; 49():2-5. PubMed ID: 28629855
[TBL] [Abstract][Full Text] [Related]
30. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
[TBL] [Abstract][Full Text] [Related]
31. Local tolerance testing under REACH: Accepted non-animal methods are not on equal footing with animal tests.
Sauer UG; Hill EH; Curren RD; Raabe HA; Kolle SN; Teubner W; Mehling A; Landsiedel R
Altern Lab Anim; 2016 Jul; 44(3):281-99. PubMed ID: 27494627
[TBL] [Abstract][Full Text] [Related]
32. FRAME and the Royal Commission on Environmental Pollution: common recommendations for assessing risks posed by chemicals under the EU REACH system.
Combes RD; Dandrea J; Balls M
Altern Lab Anim; 2003 Nov; 31(5):529-35. PubMed ID: 15598178
[TBL] [Abstract][Full Text] [Related]
33. CON4EI: CONsortium for in vitro Eye Irritation testing strategy - EpiOcular™ time-to-toxicity (EpiOcular ET-50) protocols for hazard identification and labelling of eye irritating chemicals.
Kandarova H; Letasiova S; Adriaens E; Guest R; Willoughby JA; Drzewiecka A; Gruszka K; Alépée N; Verstraelen S; Van Rompay AR
Toxicol In Vitro; 2018 Jun; 49():34-52. PubMed ID: 28866024
[TBL] [Abstract][Full Text] [Related]
34. Eye irritation.
Eskes C; Bessou S; Bruner L; Curren R; Harbell J; Jones P; Kreiling R; Liebsch M; McNamee P; Pape W; Prinsen MK; Seidle T; Vanparys P; Worth A; Zuang V
Altern Lab Anim; 2005 Jul; 33 Suppl 1():47-81. PubMed ID: 16194141
[No Abstract] [Full Text] [Related]
35. An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system.
Combes R; Barratt M; Balls M
Altern Lab Anim; 2003; 31(1):7-19. PubMed ID: 16221040
[TBL] [Abstract][Full Text] [Related]
36. Integrated testing and intelligent assessment-new challenges under REACH.
Ahlers J; Stock F; Werschkun B
Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
[TBL] [Abstract][Full Text] [Related]
37. The way forward in reproductive/developmental toxicity testing.
Spielmann H
Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
[TBL] [Abstract][Full Text] [Related]
38. Application of in vitro neurotoxicity testing for regulatory purposes: Symposium III summary and research needs.
Bal-Price AK; Suñol C; Weiss DG; van Vliet E; Westerink RH; Costa LG
Neurotoxicology; 2008 May; 29(3):520-31. PubMed ID: 18417220
[TBL] [Abstract][Full Text] [Related]
39. Development of the EpiOcular(TM) eye irritation test for hazard identification and labelling of eye irritating chemicals in response to the requirements of the EU cosmetics directive and REACH legislation.
Kaluzhny Y; Kandárová H; Hayden P; Kubilus J; d'Argembeau-Thornton L; Klausner M
Altern Lab Anim; 2011 Sep; 39(4):339-64. PubMed ID: 21942547
[TBL] [Abstract][Full Text] [Related]
40. How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?
Rovida C; Longo F; Rabbit RR
ALTEX; 2011; 28(4):273-94. PubMed ID: 22130481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
